Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells.

MLA

Ma, Ze-Jiang, et al. “Naringenin Ameliorates MASH Fibrosis via Regulating TAK1/MAPK/FoxO3a-Mediated Apoptosis in the Activated Hepatic Stellate Cells.” Biochemical and Biophysical Research Communications, vol. 734, Nov. 2024, p. 150732. EBSCOhost, https://doi.org/10.1016/j.bbrc.2024.150732.

APA

Ma, Z.-J., Yue, S.-S., Qin, B.-Y., Hu, Y.-T., Peng, A.-K., Wang, Q.-Y., & Qi, R. (2024). Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells. Biochemical and Biophysical Research Communications, 734, 150732. https://doi.org/10.1016/j.bbrc.2024.150732

Chicago

Ma, Ze-Jiang, Shan-Shan Yue, Bo-Yang Qin, Yi-Tong Hu, An-Kang Peng, Qin-Yu Wang, and Rong Qi. 2024. “Naringenin Ameliorates MASH Fibrosis via Regulating TAK1/MAPK/FoxO3a-Mediated Apoptosis in the Activated Hepatic Stellate Cells.” Biochemical and Biophysical Research Communications 734 (November): 150732. doi:10.1016/j.bbrc.2024.150732.